Dudediligence.

Immunovant, Inc

IMVTNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$11.3M

9 notices · 327,791 sh

Jan 3 to Oct 4

Reported ·

$11.6M

36 sales · 1 buy · $350.0M bought

Oct 2025 to Jun 2026

The two figures cover different periods.

7 of 36 reported sales carry the 10b5-1 box. Together they are 0.19% of the shares on issue.

PLANNED · FORM 144Jan 3 to Oct 4REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-06-26: JAY S STOUT, Form 1442026-06-26: CHRIS ADAIR VAN TUYL, Form 1442026-06-26: MELANIE GLORIA, Form 1442026-06-26: TIAGO GIRAO, Form 1442026-06-15: Atul Pande, Form 1442026-05-28: ANDREW J FROMKIN, Form 1442026-05-20: Atul Pande, Form 1442026-05-01: ROBERT G SUSMAN, Form 1442026-02-10: MICHAEL GEFFNER, Form 1442025-10-08: Stout Jay S, sold2025-10-08: Geffner Michael, sold2025-10-22: Stout Jay S, sold2025-10-22: Geffner Michael, sold2025-11-20: Gloria Melanie, sold2025-12-01: Hughes Douglas J., sold2025-12-01: Fromkin Andrew J., sold2025-12-12: Roivant Sciences Ltd., bought2025-12-18: Van Tuyl Christopher, sold2026-01-07: Stout Jay S, sold2026-01-21: Stout Jay S, sold2026-02-25: Gloria Melanie, sold2026-03-18: Van Tuyl Christopher, sold2026-04-02: Venker Eric, sold2026-04-08: Stout Jay S, sold2026-04-08: Van Tuyl Christopher, sold2026-04-08: Gloria Melanie, sold2026-04-23: Stout Jay S, sold2026-04-23: Girao Tiago, sold2026-05-01: Susman Robert Graham, sold2026-05-20: Pande Atul, sold2026-05-20: Gloria Melanie, sold2026-05-28: Fromkin Andrew J., sold2026-06-15: Pande Atul, sold2026-06-18: Van Tuyl Christopher, sold
under a no plan named▼ sale▲ buysize is dollars

Form 144 notices, newest first

2026-06-26JAY S STOUT, Chief Technology Officer$1,532,196
40,000 shno plan date144 ↗
Form 4, 2026-06-26: sold 40,000 at $38.31 Form 4 ↗
2026-06-26CHRIS ADAIR VAN TUYL, Chief Legal Officer$682,800
17,824 shno plan date144 ↗
Form 4, 2026-06-26: sold 17,824 at $38.31 Form 4 ↗
2026-06-26MELANIE GLORIA, Chief Operating Officer$678,552
17,714 shno plan date144 ↗
Form 4, 2026-06-26: sold 17,714 at $38.31 Form 4 ↗
2026-06-26TIAGO GIRAO, Chief Financial Officer$384,640
10,000 shno plan date144 ↗
Form 4, 2026-06-26: sold 10,000 at $38.46 Form 4 ↗
2026-06-15Atul Pande, Director$201,720
6,000 shplan 2025-12-26144 ↗
Form 4, 2026-06-16: sold 1,500 at $34.02 Form 4 ↗
2026-05-28ANDREW J FROMKIN, Director$7,438,710
221,951 shno plan date144 ↗
Form 4, 2026-05-29: sold 221,951 at $33.51 Form 4 ↗
2026-05-20Atul Pande, Director$157,740
6,000 shplan 2025-12-26144 ↗
Form 4, 2026-05-20: sold 6,000 at $32.00 Form 4 ↗
2026-05-01ROBERT G SUSMAN, Director$67,917
2,502 shplan 2025-12-30144 ↗
Form 4, 2026-05-01: sold 2,502 at $27.17 Form 4 ↗
2026-02-10MICHAEL GEFFNER, Chief Medical Officer$155,237
5,800 shno plan dateno Form 4 on file144 ↗